JMP Securities Initiates Coverage On AtriCure with Market Outperform Rating, Announces Price Target of $60
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Daniel Stauder has initiated coverage on AtriCure (NASDAQ:ATRC) with a Market Outperform rating and a price target of $60.
October 23, 2023 | 10:00 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AtriCure has received a Market Outperform rating from JMP Securities with a price target of $60.
The initiation of coverage by JMP Securities with a Market Outperform rating and a price target of $60 indicates a positive outlook for AtriCure. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100